Group items tagged

Scientists have been working at a rapid pace over the past year to refine a process that allows them to replicate human embryonic stem cells, without the controversial use of a human embryo. Mention of Gordon Keller, a senior stem-cell scientist working out of the MaRS centre.

Scientists have been working at a rapid pace over the past year to refine a process that allows them to replicate human embryonic stem cells, without the controversial use of a human embryo. Mention of Gordon Keller, a senior stem-cell scientist working out of the MaRS centre. Jan 2, 2009

By identifying the structure of DNA, the molecule of life, Francis Crick and James Watson revolutionized biochemistry and won themselves a Nobel Prize. At the time, Watson was only twenty-four, a young scientist hungry to make his mark. His uncompromisingly honest account of the heady days of their thrilling sprint against other world-class researchers to solve one of science's greatest mysteries gives a dazzlingly clear picture of a world of brilliant scientists with great gifts, very human ambitions, and bitter rivalries. With humility unspoiled by false modesty, Watson relates his and Crick's desperate efforts to beat Linus Pauling to the Holy Grail of life sciences, the identification of the basic building block of life. Never has a scientist been so truthful in capturing in words the flavor of his work.

Contemporary geneticists believe it might be possible to alter human DNA in a way that would allow people to live extremely long lives. Mention of Guelph scientists hosted of the University of Guelph, Ontario Agri-Food Technologies, and MaRS Landing in advancing research and commercializing that science.

Contemporary geneticists believe it might be possible to alter human DNA in a way that would allow people to live extremely long lives. Mention of Guelph scientists hosted at the University of Guelph, Ontario Agri-Food Technologies, and MaRS Landing in advancing research and commercializing that science. Feb 18, 2009

To improve early detection and treatment of cancer, a pair of Toronto scientists, Dr David Jaffray, a senior scientist in the division of biophysics and bioimaging at the Ontario Cancer Institute and Dr Christine Allen, an associate professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto has developed a technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Dec 23, 2009

Announcement that Dr Gordon Keller, the world's leading stem cell scientist will lead University Health Network's McEwen Centre for Regenerative Medicine at the MaRS Centre.

Announcement that Dr Gordon Keller, the world's leading stem cell scientist will lead University Health Network's McEwen Centre for Regenerative Medicine at the MaRS Centre. Oct 25, 2006

Mention of the Let's Talk Science All Science Challenge is taking place at the MaRS Centre, May 19. All Science Challenge - a science quiz competition for Grade 6, 7 and 8 students from over 15 schools in the greater Toronto area. Designed by students for students, it's a fun-filled day of competition and camaraderie that's part of a nationwide program to excite and inspire the next generation of scientists.

The symposium, Entrepreneurship & Commercialization in Biomedical Science, is being held on Thursday, May 14, which marks the 50th anniversary of both York University and The Gairdner Foundation. At this symposiums they will address the problem that Canadian researchers expertise to need to do in developing drugs and vaccines to address pressing medical needs. Mention of Susan Smith as a Board Member of MaRS Innovation.

The Scientist spoke with researchers who are automating and commercializing the latest technologies to aid life science work. Ameer Taha, founder, Certo Labs, Toronto and Veronika Litinski, health-care and life sciences practice lead at the MaRS Centre, a Toronto-based innovation cluster that engages researchers in commercializing their inventions were interviewed. Litinski states that "Before people start spending money on [developing] a product, we want them to think about the value chain and how the industry ecosystem is organized."

A pair of Toronto scientists has developed a unique technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Nov 20, 2009

A pair of Toronto scientists has developed a unique technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Nov 19, 2009

According to Theresa Boyle, Health Report of The Star, states that scientists have discovered the process that underlies in the development of cancer cell mutations in breast cancer. Mike Stratton who is part of the International Cancer Genome Consortium at the MaRS Centre states these "findings will go a long way in helping the consortium achieve its goal of mapping the genetic mutations in 50 different types of cancer by 2018."

Sanofi BioGENEius Challenge Canada is a biotech competition where high school students are mentored by local scientists. MaRS helps create successful global businesses from Canada's science, technology and social innovation.

The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. MaRS Innovation is one of the supporters for the conference.

The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. Parimal Nathwani, Vice President of MaRS Innovation, says"Forums like this represent an excellent opportunity for reviewing technologies and supporting collaboration across different institutions for more effective translation and commercialization opportunity."

Cynthia Goh, guest columnist, Globe and Mail states that the path of commercializing research is a "painfully gradual and meandering." Cynthia Goh, created "a lecture series to train scientist-entrepreneurs that later evolved into Entrepreneurship101 at Toronto's MaRS Discovery District - possibly the largest training program in Canada with about 1,500 registered participants each year. "

"Dr. Cavoukian, Information and Privacy Commissioner of Ontario, Canada and IBM Chief Scientist and Fellow Jonas Release a report on how organizations should act now to address the privacy risks associated with Big Data, and the analytics technologies used to make sense of these vast data sets, before such risks become realities." The report was shared at the Future of Energy Summit that was held at the MaRS Centre.

The Stem Cell Network, a national organization founded by the Canadian government in 2001 that today is more than 100 investigators strong and has received over $60 million in government funding. The Stem Cell Network is helping to create a vibrant and interactive community.

The Ontario Institute for Cancer Research (OICR) is applying the newest concepts in life sciences-stem cell therapies, personalized medicine-to one of the oldest diseases.

The Ontario Institute for Cancer Research (OICR) is a new center of excellence. It is moving Ontario to the forefront of discovery and innovation in cancer research